http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101790979-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6aa6f235af2723c0b2bf17f8c24a7f26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c95ac09001fedd07e719ca14b37923e
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01P7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N25-04
filingDate 2010-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2013-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b823e4991ca379761a54870af9868393
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67d6e1ee0ad74ae7986bcefd8e79b854
publicationDate 2013-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-101790979-B
titleOfInvention Emamectin benzoate suspending agent and preparation method thereof
abstract The invention discloses an emamectin benzoate suspending agent and a preparation method thereof. The emamectin benzoate suspending agent comprises the following components by weight percent: 0.2-5 percent of emamectin benzoate, 1-10 percent of wetting dispersant, 2-10 percent of antifreeze agent, 1-6 percent of stabilizing agent, 1-5 percent of defoamer, 0.1-1 percent of thickening agent, 0.1-1 percent of preservative and the balance of water. In the emamectin benzoate suspending agent, an anion active agent is added, thereby the problems of grinding and livering of the emamectin benzoate are solved. Organic solvent harmful to the human and the environment is not adopted in the invention, thereby reducing pollution of the organic solvent to the environment; besides, the adopted dosage form has lower cost, thereby effectively reducing the solvent cost, the package cost and the transportation expense.
priorityDate 2010-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101642114-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134919
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24667
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID7107
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454174744
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420244777
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419511923
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3084116
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57345970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID96917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID417430547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1004
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544560
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416217522
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25113562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420560024
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453678473
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4224596
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6434889
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448352729
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16043
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578986
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579328
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419477551
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID7107
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449298374
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2749041
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57507888
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3013997
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962

Total number of triples: 48.